Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Scleroderma is a complex connective tissue disease involving three interconnected pathophysiological axes: vascular hyperactivity and remodelling, immune system dysfunction and over-activation of fibroblasts at the origin of the fibrosis process in the skin and organs. Given that this pathology occurs preferentially in mature subjects, it is possible to suggest a potential inductive role for senescent fibroblasts, which would be responsible for activating and/or maintaining the immune response and systemic inflammation. Our hypothesis is that fibroblasts play a predominant role in the genesis and maintenance of this pathology.

Who May Be Eligible (Plain English)

Who May Qualify: FOR PATIENTS WITH SCLERODERMA : - Person who has given written consent - Person with systemic scleroderma FOR CONTROL PARTICIPANTS : - Person who has given written consent - Person undergoing plastic, cosmetic and reconstructive surgery Who Should NOT Join This Trial: FOR PATIENTS WITH SCLERODERMA : - Person not affiliated to or not benefiting from a social security scheme - Person subject to a legal protection measure (curatorship, guardianship) - Person subject to a legal protection measure - An adult who is incapable or unable to give consent - Minors FOR CONTROLLED PARTICIPANTS : - Person suffering from a chronic disease or under chronic treatment for autoimmune, inflammatory or dermatological diseases - Person not affiliated to or not benefiting from a social security scheme - Person under legal protection (curatorship, guardianship) - Person subject to a legal protection measure - An adult who is incapable or unable to give consent - Minors Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: FOR PATIENTS WITH SCLERODERMA : * Person who has given written consent * Person with systemic scleroderma FOR CONTROL PARTICIPANTS : * Person who has given written consent * Person undergoing plastic, cosmetic and reconstructive surgery Exclusion Criteria: FOR PATIENTS WITH SCLERODERMA : * Person not affiliated to or not benefiting from a social security scheme * Person subject to a legal protection measure (curatorship, guardianship) * Person subject to a legal protection measure * An adult who is incapable or unable to give consent * Minors FOR CONTROLLED PARTICIPANTS : * Person suffering from a chronic disease or under chronic treatment for autoimmune, inflammatory or dermatological diseases * Person not affiliated to or not benefiting from a social security scheme * Person under legal protection (curatorship, guardianship) * Person subject to a legal protection measure * An adult who is incapable or unable to give consent * Minors

Treatments Being Tested

PROCEDURE

Skin samples

* Scleroderma group: skin biopsy for scleroderma patients * Control group: recovery of resected tissue from patients undergoing plastic, reconstructive and aesthetic surgery.

OTHER

Analysis of fibroblasts

Analysis of samples by RNA sequencing

Locations (1)

CHU Dijon Bourgogne
Dijon, France